The Point of Care Diagnostics Testing Market is witnessing significant growth as healthcare providers increasingly demand rapid, convenient, and accessible diagnostic solutions. According to Market Research Future, the market was valued at USD 57.71 billion in 2024 and is projected to reach USD 157.87 billion by 2035, expanding at a CAGR of 9.58% during 2025–2035.

Point-of-care diagnostics allow testing to be performed close to patients, reducing waiting times and supporting faster clinical decision-making. Increasing chronic disease prevalence, infectious disease concerns, and the growing need for preventive healthcare are major factors supporting market expansion.

The market includes glucose monitoring, cardiometabolic monitoring, infectious disease testing, coagulation monitoring, pregnancy and fertility testing, hematology testing, cancer and tumor marker testing, urinalysis, cholesterol testing, and drugs-of-abuse testing. Hospitals and clinics remain important end users, while homecare and self-testing are gaining momentum.

Technological developments in portable devices, molecular diagnostics, biosensors, immunoassays, and artificial intelligence are further transforming the industry. North America currently leads the market, supported by advanced healthcare infrastructure and strong adoption of innovative diagnostic technologies.

Overall, decentralized healthcare, personalized medicine, digital health integration, and increasing demand for immediate results are expected to create substantial opportunities for market participants.

Explore additional reports to understand evolving market landscapes:

Medical Billing Market Size

Medical Billing Market Share

Medical Cannabis Market Trends

Medical Cannabis Market Growth

Medical Cannabis Market Demand